SFLMaven

SFLM

Shell Companies · Financial Services

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Winston Score History

The full picture

SFLMaven Corp. is a small specialty pharmaceutical company focused on developing and commercializing generic and specialty drug products. The company targets niche prescription drug markets, aiming to bring lower-cost alternatives to branded medications to patients and healthcare providers in the United States.

The company generates revenue through drug product sales, though its financial profile reflects an early or development-stage business, with minimal reported revenue and thin or negative margins. SFLMaven operates primarily in the U.S. market and competes in a crowded generic drug space dominated by much larger players like Teva and Hikma. The primary risk facing the company is its very small scale — limited cash resources, regulatory hurdles from the FDA, and intense pricing pressure in generics make it difficult for micro-cap pharmaceutical companies to reach sustainable profitability.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-100.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+97.0% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

100.0%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~0 months

$0 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

SFLMaven has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

Data not available

Profit after running costs

Operating Margin

N/A

Data not available

Return on the money invested

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

Data not available

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial